EMA approves new manufacturing site in France for Moderna’s COVID-19 vaccine


Article content

The European Medicines Agency (EMA) on Friday approved a new manufacturing site for the production of Moderna Inc’s COVID-19 vaccine finished product.

The site is operated by Recipharm and located in Monts, France, EMA’s committee for human medicines said. (Reporting by Vishwadha Chander in Bengaluru; Editing by Shounak Dasgupta)